We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$7.81M
Cap. Flow
-$11.3M
Cap. Flow %
-11.27%
Top 10 Hldgs %
11.69%
Holding
238
New
12
Increased
100
Reduced
117
Closed
1

Top Buys

Rank Stock Value
1
ARHS icon
Arhaus
ARHS
+$228K
2
AR icon
Antero Resources
AR
+$208K
3
MTDR icon
Matador Resources
MTDR
+$203K
4
SSTK icon
Shutterstock
SSTK
+$194K
5
EXE
Expand Energy Corp
EXE
+$188K

Top Sells

Rank Stock Value
1
ELF icon
e.l.f. Beauty
ELF
+$919K
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$772K
3
CPRX
Catalyst Pharmaceutical
CPRX
+$637K
4
ENPH icon
Enphase Energy
ENPH
+$535K
5
META icon
Meta Platforms (Facebook)
META
+$528K

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Healthcare 26.32%
3 Consumer Discretionary 12.34%
4 Industrials 8.94%
5 Financials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENPH icon
126
Enphase Energy
ENPH
$4.96B
$341K 0.34%
1,230
-1,984
-62% -$535K
NMRK icon
127
Newmark Group
NMRK
$2.66B
$339K 0.34%
41,743
-989
-2% -$10.2K
PNFP icon
128
Pinnacle Financial Partners Inc
PNFP
$15.9B
$333K 0.33%
4,167
+217
+5% +$17.3K
FNA
129
DELISTED
Paragon 28, Inc.
FNA
$329K 0.33%
17,349
+2,399
+16% +$44.2K
SSNC icon
130
SS&C Technologies
SSNC
$18.1B
$325K 0.32%
6,808
-3,071
-31% -$177K
MTCH icon
131
Match Group
MTCH
$9.19B
$324K 0.32%
6,899
+1,179
+21% +$74.1K
ZM icon
132
Zoom
ZM
$28.2B
$321K 0.32%
4,362
-1,957
-31% -$186K
SGEN
133
DELISTED
Seagen Inc. Common Stock
SGEN
$317K 0.32%
2,315
-476
-17% -$77.5K
ACAD icon
134
Acadia Pharmaceuticals
ACAD
$4.43B
$315K 0.31%
21,054
-11,543
-35% -$187K
QCOM icon
135
Qualcomm
QCOM
$155B
$314K 0.31%
2,782
-925
-25% -$127K
RPD icon
136
Rapid7
RPD
$645M
$314K 0.31%
10,891
+1,888
+21% +$117K
BPMC
137
DELISTED
Blueprint Medicines
BPMC
$312K 0.31%
7,325
+1,320
+22% +$84.8K
REGN icon
138
Regeneron Pharmaceuticals
REGN
$78.5B
$308K 0.31%
447
-58
-11% -$36.5K
PAYC icon
139
Paycom
PAYC
$7.64B
$306K 0.3%
926
-402
-30% -$138K
IPAR icon
140
Interparfums
IPAR
$3.99B
$303K 0.3%
3,436
-2,959
-46% -$234K
IMAX icon
141
IMAX
IMAX
$2.62B
$291K 0.29%
19,674
– –
CGNX icon
142
Cognex
CGNX
$10.9B
$290K 0.29%
6,991
-5,902
-46% -$267K
CSTL icon
143
Castle Biosciences
CSTL
$855M
$289K 0.29%
14,455
+485
+3% +$13.6K
FSLY icon
144
Fastly Inc
FSLY
$3.55B
$289K 0.29%
31,892
-5,600
-15% -$59.6K
ORCL icon
145
Oracle
ORCL
$374B
$289K 0.29%
4,737
-2,839
-37% -$208K
XYZ
146
Block Inc
XYZ
$48.4B
$289K 0.29%
5,263
-2,452
-32% -$174K
CRWD icon
147
CrowdStrike
CRWD
$194B
$288K 0.29%
6,992
-3,016
-30% -$138K
CUBI icon
148
Customers Bancorp
CUBI
$2.66B
$285K 0.28%
8,973
+799
+10% +$28.3K
CHEF icon
149
Chefs' Warehouse
CHEF
$4.71B
$284K 0.28%
7,759
+2,768
+55% +$96.7K
HLI icon
150
Houlihan Lokey
HLI
$8.77B
$281K 0.28%
2,901
+18
+0.6% +$1.46K
4 5
6
7 8

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Capital Impact Advisors held 238 positions worth $100M, down 7.2% from $108M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Impact Advisors withdrew a net $11.3M in Q3 2022, closing 1 position and reducing 117 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $772K position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Capital Impact Advisors opened a new position in Ginkgo Bioworks worth $118K.

  • Capital Impact Advisors's largest Q3 2022 buy was Ginkgo Bioworks: 1,374 shares worth $118K.
  • Capital Impact Advisors added most to Arhaus in Q3 2022, an estimated $228K increase.
  • Capital Impact Advisors's biggest Q3 2022 reduction was e.l.f. Beauty, cutting an estimated $919K.
  • Capital Impact Advisors fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $772K.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $100M portfolio in Q3 2022.
  • Capital Impact Advisors opened 12 new positions and closed 1 in Q3 2022.
  • Capital Impact Advisors's portfolio value fell 7.2% quarter-over-quarter to $100M.

Based on Capital Impact Advisors's 13F filing for Q3 2022, filed 22 Nov 2022.